Meloxicam

Producers shown on SFDA

(Record date:31/08/2021）

Producers shown on EP

(Quoted from EP website；record date:31/08/2021）

Producer:Shandong Xinhua Pharmaceutical Co., Ltd., established in Jiaodong Anti Japanese base in 1943, is the first chemical synthetic pharmaceutical enterprise in China, an important global production and export base of antipyretic and analgesic drugs, and an important domestic manufacturer of cardio cerebrovascular, anti infection and central nervous system. It has three pillar industries of chemical raw materials, pharmaceutical preparations and pharmaceutical intermediates, five industrial parks and 13 subsidiaries. The annual production capacity of chemical APIs is 40000 tons, pharmaceutical intermediates is 500000 tons, solid preparations are 28 billion tablets (tablets), and injections are 1 billion.

At present, all the drugs in production of Xinhua Pharmaceutical have passed the new national GMP certification, 18 products have passed the FDA inspection, 10 products have obtained the EU cos certificate, and the tablets have passed the MHRA audit of the UK drug and health products administration. More than 3 billion tablets have been exported to the EU high-end market, It has become one of the first 15 leading enterprises implementing the internationalization strategy of preparations in China and one of the top ten enterprises in the export of preparations in China.

Staff size:About 7000 persons

Registered capital:RMB 627 million 400 thousand

Producer:Zhejiang Xianju Pharmaceutical Co., Ltd., formerly known as Xianju pharmaceutical factory, was founded in 1972. It is a professional manufacturer of steroidal drugs in China. The total share capital of the company is 916212166 yuan, covering an area of 650 mu. At present, it has more than 3900 employees, including 15 technical personnel and 35 sales personnel. It is a comprehensive manufacturer of APIs and preparations.

The company has nearly 200 varieties and has a production capacity of 300 tons of API, 10 billion tablets, 500 million capsules, 500 million water needles, 20 million lyophilized powder injections, 35 million creams and 60 million bags of granules.

At present, all products of the company have passed the national GMP certification. 13 products such as vecuronium, prednisone acetate, prednisolone and medroxyprogesterone acetate have been certified by FDA; Nine products including cyproterone acetate, prednisolone and norethisterone have obtained the EU CEP certificate; Prednisolone, betamethasone dipropionate and betamethasone valerate have passed the KFDA certification in Korea; Small volume injection production line and comprehensive solid preparation production line (I) have passed the invima certification in Colombia.

Staff size:About 4000 persons

Registered capital:RMB 989 million 200 thousand

Producer:Jiangsu Feima Pharmaceutical Co., Ltd., located in Nantong Economic and Technological Development Zone, is a high-tech pharmaceutical enterprise rising in Nantong pharmaceutical industry in recent years. It was registered and established in February 2003. Pegasus pharmaceutical has a total investment of 100 million yuan and a registered capital of 35 million yuan. At present, solid preparation workshop, API synthesis workshop, Chinese medicine extraction pilot workshop and relevant auxiliary production projects and facilities have been built. The company won the title of Nantong integrity qualified enterprise in 2006 and Jiangsu pharmaceutical integrity enterprise in 2008; From 2007 to 2014, the company was continuously recognized as a high-tech enterprise in Jiangsu Province. In 2008, the company also won the advanced unit of talent work in Nantong Economic and Technological Development Zone. Through years of unremitting efforts, Jiangsu Pegasus pharmaceutical has continuously improved its product structure and has obtained 13 product approvals, 6 new drug certificates and 4 patents.

Registered capital:RMB 35 million

Producer:Sichuan baojiantang Pharmaceutical Co., Ltd. is established by Chengdu Beite Pharmaceutical Group's acquisition of Haike pharmaceutical branch of Sichuan Shenghe Pharmaceutical Co., Ltd. with its production address at No. 66, Kelin Road, Wenjiang District, Chengdu, covering an area of about 106 mu. The company has four production workshops, including traditional Chinese medicine extraction workshop, solid preparation workshop, liquid preparation workshop and API workshop, with a total of eight production lines. At present, the main products are: Tangmaikang granule (national variety), Xiaoer kekening syrup, Xiegan capsule, betahistine hydrochloride oral liquid and other 33 varieties.

Registered capital:RMB 182 million 776 thousand and 863

Producer:Kangya of Ningxia Pharmaceutical Co.,Ltd. founded in September 1996 and located in Yinchuan, Ningxia,China.The company is a comprehensive high-tech pharmaceutical enterprise combining R&D, production and sell together for pharmaceutical formulations and bulk drugs. Kangya of Ningxia Pharmaceutical Co., Ltd. covers an area of 130,000 square meters.

The company passed GMP certification in August 2004. The company has been a high-tech enterprise in the autonomous region since 1998; Since 2000, the company has obtained 7 new drug certificates, 14 production approvals, more than 20 new products under research and applied for 6 national invention patents.

Registered capital:RMB 53 million 206 thousand and 500